Received Feb 4, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| RSV | RSV (AREXVY) | GLAXOSMITHKLINE BIOLOGICALS | 2 | LM47J7 | IM / LA |
Reported Symptoms: Narrative: Patient received his RSV vaccine on 12/21/2023. Patient came in to the facility on 10/29/24 and received a second RSV vaccine. RSV is only indicated as a single lifetime dose vaccine. Patient did not report any adverse events. Other Relevant HX: Patient received his RSV vaccine on 12/21/2023. Patient came in to the facility on 10/29/24 and received a second RSV vaccine. RSV is only indicated as a single lifetime dose vaccine. Patient did not report any adverse events. Other; N/A